MENU
FEB 24, 2021 10:30 AM PST

The New xMAP® INTELLIFLEX: Technology You Trust. Versatility You Want

Sponsored by: LUMINEX
C.E. Credits: P.A.C.E. CE Florida CE
Speakers
  • Senior Director, Global Scientific Affairs
    Biography
      Dr. Dunbar received a B.S. degree in Microbiology and Immunology, and a MBA from the University of Maryland. She completed a Ph.D. in Medical Microbiology and Immunology from the University of South Alabama and a post-doctoral fellowship in Clinical and Public Health Microbiology at Baylor College of Medicine. She was then the clinical laboratory director at Virus Reference Laboratory in Houston, Texas. Dr. Dunbar joined Luminex as a Senior Scientist in 1999 and served as Senior Director of the Biology Research and Development group for eight years. This group developed assay protocols, techniques, and helped to determine the best practices for xMAP Technology. During this time, the laboratory developed more than one hundred multiplexed assay panels for proteins, nucleic acids and other biomolecules. Currently, Dr. Dunbar is the Senior Director of Global Scientific Affairs for Luminex. She has more than forty publications in the peer-reviewed literature and numerous abstracts presented at scientific conferences.
    • Sales Development Manager, Licensed Technologies Group, Luminex Corporation

    Abstract

    Meet xMAP® Technology all over again. Over the past 25 years, Luminex’s xMAP Technology has emerged as the worldwide leader in bead-based multiplexing. The new xMAP® INTELLIFLEX provides all of the benefits of xMAP with additional features and capabilities that will allow users to expand their research even further. INTELLIFLEX is the only compact, flow-based multiplex platform that combines the proven performance of xMAP Technology with modern features to enhance performance, empower assay development innovation, and simplify the user experience. No other multiplex platform combines low- and high-plex capabilities, quick time to reliable results, and the ability to acquire data for two parameters per analyte simultaneously. In this presentation, two Luminex experts will discuss some of the exciting applications made possible by this new xMAP System. Also included is an overview of the latest research currently being conducted using this robust platform—including recent work in immunogenicity, where xMAP Technology enabled the simultaneous screening of anti-drug-antibodies and isotyping in a single multiplex assay. Additionally, our speakers will highlight the innovative features of INTELLIFLEX, including the new second reporter channel, which allows users to acquire double the data for each analyte, saving time and precious sample.

    Find out more: https://www.luminexcorp.com/intelliflex/#overview

    Learning Objectives:

    1. Learn about why Luminex’s xMAP bead-based technology is the gold-standard in multiplexing, including how xMAP emerged as the leading multiplexing platform for life science research over the past 25 years

    2. Become familiar with the applications of xMAP Technology, including how it has been used in drug discovery and immunogenicity studies to expand the number of data points per well, accelerating research

    3. Discover the benefits of xMAP INTELLIFLEX—Luminex’s newest xMAP instrument—and the novel second reporter channel, which supports the simultaneous measurement of two reporter fluorophores per analyte in each well.

    For Research Use Only. Not for use in diagnostic procedures.


    Show Resources
    You May Also Like
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    OCT 29, 2020 6:00 AM PDT
    C.E. CREDITS
    OCT 29, 2020 6:00 AM PDT
    Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
    MAR 16, 2021 10:00 AM PDT
    C.E. CREDITS
    MAR 16, 2021 10:00 AM PDT
    Date: March 16, 2021 Time: 10:00am (PST) Scientific progress and breakthroughs today are often too expensive for most institutions to acquire. Each year, the National Institutes of Health (N...
    APR 01, 2021 8:00 AM PDT
    C.E. CREDITS
    APR 01, 2021 8:00 AM PDT
    Date: April 01, 2021 Time: 8:00am (PST), 11:00am (EST) Generating therapeutic antibodies is far more challenging than obtaining antibodies that merely recognize their targets. Engineering po...
    Loading Comments...
    Show Resources
    Attendees
    • See more